Innovation Endeavors — 2017 Investments
4 investments dated 2017 · listed companies and verified rows first · show all
Citrine provides an AI platform for product development used across organizations, with expertise in materials discovery and advanced manufacturing optimization.
Advanced ManufacturingAI & Machine LearningDeep TechEnterprise SoftwareNew MaterialsRedwood City, US
Greg Mulholland(CEO and Co-founder)inBryce Meredig(Co-founder)inRahim Lakhani(Executive Officer)in
BoardScott Brady(Director)inMark Cupta(Director)inAmar Hanspal(Director)
Co-investorsAlumni VenturesB&C Innovation InvestmentsCm VentureDCVC (Data Collective)DYDX CapitalEndeavor8+8 more
project44 is a supply chain software company serving logistics and supply chain operations teams to improve visibility and efficiency across supply networks.
AI & Machine LearningEnterprise SoftwareLogistics & Supply ChainSaaSChicago, US
Jett McCandless(Founder)in
Co-investors8VCBtomorrow VenturesChicago VenturesCollective LiquidityCorsa VenturesCota Capital+19 more
GRObio (GRO Biosciences) develops protein therapeutics using non-standard amino acids (NSAAs) via its GRO platform, aiming to improve protein potency, stability, and function.
BiotechDeep TechHealthtechCambridge, US
Daniel J Mandell(Chief Executive Officer)Tracey Lodie(Executive Officer)inChristopher Gregg(Director)
BoardMing Fang(Director)Bruce Beutel(Director)Dan Becker(Director)
Co-investorsLeaps by BayerREDMILEAlumni VenturesDigitalis VenturesDreamers VCOS Fund+3 more
Plenty builds controlled environment farms that use vertical growing methods to produce food using significantly less land and water than conventional agriculture.
AgTechFoodTechVirginia, US
Mary S Moore(Executive Officer, Director)David Hughes Sommers(Executive Officer)Arama KukutaiinMatt Barnard(Founder)Nate Storey(Founder)
Co-investorsDCM VenturesDYDX CapitalNFXSoftBank Vision FundWestern Technology InvestmentBezos Expeditions+4 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




















